“HOT” stock: Pro Medicus (PMD)
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, notes that Morgans has added Pro Medicus (PME) to the Best Ideas List.
Stock picks from our team of market veterans.
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, notes that Morgans has added Pro Medicus (PME) to the Best Ideas List.
Seven magnificent tech giants have powered the rise of the US stock market. They’re now a tick over a third of the benchmark US S&P 500 index. This year they’re off to a mixed start. If you’re concerned you might have too much exposure to them, here are some index tracking ETFs to consider.
For the week ending Friday 6th February 2026, FNArena tracked 23 upgrades and 14 downgrades for ASX-listed companies from brokers monitored daily.
Today I’m standing on the shoulders of great business builders to argue that this tech sell off is a buying opportunity. Stay with me on this!
In this article, we look at how our model portfolios have performed so far in 2026.
For the week ending Friday, January 30, 2026, FNArena tracked twenty-four upgrades and twenty-six downgrades for ASX-listed companies from brokers monitored daily.
Here are two US small-cap ETFs that provide exposure to stronger US economy this year.
For the week ending Friday 16 January 2026, FNArena registered no less than 15 upgrades in ratings for ASX-listed stocks.
Here are three ETFs that could benefit from Great Power contestation for natural resources.
We’ve made some changes to our income and growth portfolios for 2026 to consider the dominant investment themes we expect to apply. We’ve also rebalanced the portfolios.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.